Cardinal Health’s enteral feeding pump, Kangaroo OMNI, is now available in the US.
According to the US-based device maker, the feeding pump can deliver thick, homogenised, and blended formulas which provide personalised nutrition and hydration in line with the patient's dietary requirements. Thick formula is defined as enteral fluid of smooth consistency that is categorised as level 2, 3, or 4 drinks within the International Dysphagia Diet Standardisation Initiative (IDDSI) framework.
Cardinal Health claims the feeding pump can offer a global solution, with user friendly interface capable of translating screen content into 19 languages.
Seanne Wedman, a clinical products consultant at Cardinal Health Canada and a former nurse, attested to the Kangaroo OMNI's impact on patients. Wedman, whose own child has relied on enteral feeding since birth, highlighted the device's compact size and portability, which enables her son to maintain a regular childhood routine.
"Kangaroo OMNI has innovative modifications for improved ease of use and portability when compared to other Kangaroo pumps," said Wedman.
The device also includes a 30-day feeding history transmission feature, giving healthcare providers access to patient data and includes interruption monitoring, which displays any missed nutrition when the pump is turned off.
"Product innovation plays an essential role in our portfolio lifecycle process. Kangaroo OMNI was designed to help improve the lifestyle of enteral feeding patients and caregivers through ease of use, intelligence, versatility and portability," said Kelley Moffett, senior vice president, Global Medical Products, Medical Segment, Cardinal Health. "Kangaroo OMNI provides patients and caregivers with the lightest, smallest and quietest Kangaroo feed and flush enteral feeding pump, while delivering a wider variety of commercially available enteral formulas to the patient."
In August 2023, Cardinal Health released a new feeding device, the NTrainer System 2.0 to improve neonatal feeding. The device is a US Food and Drug Administration (FDA) Class II biofeedback device designed for supporting newborns and infants born prematurely
